StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Osiris Therapeutics Inc

Enter Symbol or Keywords

StockDiagnostics.com Maintains a Suspended OPS Ranking on Osiris Therapeutics

Stock Quote: (NGM:OSIR)

11/12/2009

5.80

-0.10

-1.69%

29,580

StockDiagnostics.com Maintains a Suspended OPS Ranking on Osiris Therapeutics

Last

Price Change

% Chg

Volume

Sarasota, FL, November 12, 2009-StockDiagnostics.com has reiterated its suspended OPS Ranking for Osiris Therapeutics, Inc. (NASDAQ:OSIR) in its quarter ended September 30, 2009 because of its earlier ... read full story

Website Address:	www.osiristx.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: OSIR

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: OSIR

08/18/2010

Osiris Therapeutics' EBITDA Turns Positive for its Second Quarter

08/17/2010

Revenue for Osiris Therapeutics Increased by 41.76% over its most recent 12 months reports T12-NEWS

08/16/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Osiris Therapeutics

... more OSIR exclusives

Other News Sources: OSIR

01/03/2012

Osiris Therapeutics Provides Update on Groundbreaking Stem Cell Trial for Type 1 Diabetes

12/15/2011

Proteonomix, Inc. (OTCBB: PROT) to Begin Clinical Study With University of Miami

11/22/2011

Osiris Therapeutics to Present at the 23rd Annual Piper Jaffray Healthcare Conference

... more OSIR news from other sources

Daily Market Updates

02/08/2012

Markets Open Mixed and Move Up Slightly in Early Trading

U.S. markets are up modestly in early trading as investors hope that a Greek austerity deal will be coming soon in order to avoid a chaotic default. The European Central Bank has made key concessions regarding its holdings of Greek government bonds, ... read full story